Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL298364 | 0.79 | KCNN4 (0.47) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL11439383 | 0.76 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL3889625 | 0.76 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL9245544 | 0.73 | CYP1A2 (0.44) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL3889984 | 0.73 | MAPK1 (0.50) | KCNN4ALDH1A1TSHRMAPK1TAAR1 | |
| Methyl Alcohol SCHEMBL28881402 | 0.71 | ALDH1A1 (0.44) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL2125552 | 0.71 | KCNN4 (0.41) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL230628 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL8178 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL11658410 | 0.67 | MAPK1 (0.43) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1243608-B1 | Process for producing poly(alkylene oxide) and product thereof | MITSUI CHEMICALS INC (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-6936684-B2 | Poly (alkylene oxide) prepared in the presence of a phosphazenium salt or compound | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 2005-08-30 | — | — | US | disclosed |
| US-6664365-B2 | Polymerization catalyst | MITSUI CHEMICALS & SKC POLYURETHANES INC. (JP) | 2003-12-16 | — | — | US | disclosed |
| US-20030225244-A1 | Poly (alkylene oxide) prepared in the presence of a phosphazenium salt or compound | MITSUI CHEMICALS, INC. (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-0791600-B1 | Phosphazenium salt and preparation process thereof | MITSUI CHEMICALS INC (JP) | 2003-06-25 | — | — | EP | disclosed |
| US-20030105361-A1 | PROCESS FOR PRODUCING POLY (ALKYLENE OXIDE) IN THE PRESENCE OF A PHOSPHAZENIUM SALT OR COMPOUND | MITSUI CHEMICALS & SKC POLYURETHANES INC. (JP) | 2003-06-05 | — | — | US | disclosed |
| EP-1243608-A2 | Process for producing poly(alkylene oxide) and product thereof | Mitsui Chemicals, Inc. (JP) | 2002-09-25 | — | — | EP | disclosed |
| US-5990352-A | A POLYMERIZATION CATALYST FOR FORMING A POLYETHER | MITSUI CHEMICALS, INC. (JP) | 1999-11-23 | — | — | US | disclosed |
| EP-0791600-A1 | Phosphazenium salt and preparation process thereof, and process for producing poly(alkylene oxide) | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225244-A1 | Poly (alkylene oxide) prepared in the presence of a phosphazenium salt or compound | PHOSPHO1, DEGS1, PLCB1 | KCNN4 20/4885ALDH1A1 4259/4885TSHR 4288/4885 |
| US-20030105361-A1 | PROCESS FOR PRODUCING POLY (ALKYLENE OXIDE) IN THE PRESENCE OF A PHOSPHAZENIUM SALT OR COMPOUND | PHOSPHO1, PLCB1, DEGS1 | KCNN4 12/4885ALDH1A1 4590/4885TSHR 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.